Bulletin
Investor Alert

New York Markets After Hours

Galapagos N.V. ADR

NAS: GLPG

GO
/marketstate/country/us

After Hours

/zigman2/quotes/205153380/composite

$

139.18

Change

0.00 0.00%

Volume

Volume 540

Sep 25, 2020, 4:30 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205153380/composite

Today's close

$ 132.47

$ 139.18

Change

+6.71 +5.07%

Day low

Day high

$135.12

$139.39

Open
Open: 135.21

52 week low

52 week high

$112.00

$274.03

Open

Market cap

$8.74B

Average volume

148,511

P/E ratio

72.57

Rev. per Employee

$567,924

EPS

1.92

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/glpg

MarketWatch News on GLPG

  1. Gilead Bets Heavily in a Cancer Biotech Acquisition

    10:28 a.m. Sept. 14, 2020

    - Barron's Online

  2. Gilead reaches $21 billion deal for Immunomedics

    4:30 p.m. Sept. 13, 2020

    - MarketWatch.com

  3. FDA Rejects Potential Gilead Blockbusters, Scrambling Drug Stocks

    10:42 a.m. Aug. 19, 2020

    - Barron's Online

  4. Galapagos stock price target cut to $155 from $187 at Stifel Nicolaus

    6:58 a.m. Aug. 19, 2020

    - Tomi Kilgore

  5. Galapagos' stock plunges 29% premarket, as partner Gilead's arthritis drug won't be approved in current form

    6:21 a.m. Aug. 19, 2020

    - Tomi Kilgore

  6. Galapagos downgraded to hold from buy at Stifel Nicolaus

    7:25 a.m. July 10, 2020

    - Tomi Kilgore

  7. Galapagos stock price target cut to $193 from $298 at Stifel Nicolaus

    7:25 a.m. July 10, 2020

    - Tomi Kilgore

  8. Galapagos downgraded to underperform from neutral at BofA Securities

    10:35 a.m. Feb. 24, 2020

    - Tomi Kilgore

  9. Galapagos stock price target raised to $298 from $188 at Stifel Nicolaus

    10:02 a.m. Feb. 24, 2020

    - Tomi Kilgore

  10. Sanofi Stock Is Undervalued, J.P. Morgan Says

    11:22 a.m. Jan. 6, 2020

    - Barron's Online

  11. Galapagos downgraded to neutral from overweight at J.P. Morgan

    8:52 a.m. Jan. 6, 2020

    - Tomi Kilgore

  12. European Stocks Slip on China Concerns

    6:54 a.m. Nov. 11, 2019

    - Barron's Online

  13. Europe stocks sag on China trade and Hong Kong violence concerns

    6:37 a.m. Nov. 11, 2019

    - Steve Goldstein

  14. Gilead Reports Earnings Today. Here’s What to Expect.

    6:10 a.m. Oct. 24, 2019

    - Barron's Online

  15. Galapagos downgraded to market perform at Bernstein

    9:12 a.m. Oct. 18, 2019

    - Tomi Kilgore

  16. Gilead Rises On Promising Data

    8:37 a.m. Oct. 11, 2019

    - Barron's Online

  17. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/glpg

Other News on GLPG

  1. Galapagos (GLPG) Receives a Hold from Stifel Nicolaus

    2:05 p.m. Today

    - SmarterAnalyst

  2. Galapagos ADR (GLPG) Investor Presentation - Slideshow

    2:02 p.m. Today

    - Seeking Alpha

  3. Gilead and Galapagos' filgotinib OK'd in Europe for rheumatoid arthritis

    1:20 p.m. Today

    - Seeking Alpha

  4. Gilead's Rheumatoid Arthritis Drug Gets Approval in Japan

    9:30 a.m. Today

    - Zacks.com

  5. New Strong Sell Stocks for September 25th

    7:48 a.m. Today

    - Zacks.com

  6. Gilead's Jyseleca Ok'd in Japan for rheumatoid arthritis

    6:27 a.m. Today

    - Seeking Alpha

  7. Galapagos (GLPG) Surges: Stock Moves 8.8% Higher

    9:28 a.m. Sept. 14, 2020

    - Zacks.com

  8. Gilead Reaches Deal to Buy Immunomedics for $21 Billion

    8:31 p.m. Sept. 13, 2020

    - Cara Lombardo

  9. PTON, GLPG among premarket gainers

    8:25 a.m. Sept. 11, 2020

    - Seeking Alpha

  10. Galapagos' Ziritaxestat successful in systemic sclerosis study

    5:47 a.m. Sept. 11, 2020

    - Seeking Alpha

  11. Remdesivir Data Leaves Gilead Stock Well-Positioned to Rally

    7:45 a.m. Aug. 28, 2020

    - InvestorPlace.com

  12. Galapagos downgraded to Hold at Jefferies

    1:38 p.m. Aug. 25, 2020

    - Seeking Alpha

  13. What Made H.C. Wainwright Downgrade Galapagos’ Stock?

    7:55 a.m. Aug. 24, 2020

    - SmarterAnalyst

  14. Gilead Sciences Fails At Filgotinib - What's Next?

    9:52 a.m. Aug. 20, 2020

    - Seeking Alpha

  15. Loading more headlines...
/news/pressrelease/company/us/glpg

Press Releases on GLPG

  1. Correction: Jyseleca(R) (filgotinib) approved in Japan for rheumatoid arthritis

    6:34 a.m. Today

    - GlobeNewswire

  2. Jyseleca(R) (filgotinib) approved in Japan for rheumatoid arthritis

    6:33 a.m. Today

    - GlobeNewswire

  3. Correction: Jyseleca(R) (filgotinib) approved in Japan for rheumatoid arthritis

    2:13 a.m. Today

    - Globe Newswire

  4. Jyseleca(R) (filgotinib) approved in Japan for rheumatoid arthritis

    2:00 a.m. Today

    - Globe Newswire

  5. Oxurion NV Business Update - H1 2020

    11:45 a.m. Sept. 17, 2020

    - GlobeNewswire

  6. Gilead, AbbVie and Glaxo Stock on Sale

    7:15 a.m. Sept. 14, 2020

    - Baystreet.ca

  7. Loading more headlines...

Rates »

Link to MarketWatch's Slice.